Prescription drug · ANDA
perphenazine NDC 70771-1044
Perphenazine 16 mg/1 · Tablet · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1044-1 | 70771104401 | 100 TABLET in 1 BOTTLE (70771-1044-1)Marketed from Jul 16, 2020 | |
| 70771-1044-4 | 70771104404 | 10 BLISTER PACK in 1 CARTON (70771-1044-4) / 10 TABLET in 1 BLISTER PACK (70771-1044-2)Marketed from Jul 16, 2020 | |
| 70771-1044-5 | 70771104405 | 500 TABLET in 1 BOTTLE (70771-1044-5)Marketed from Jul 16, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- perphenazine
- Generic name (nonproprietary)
- perphenazine
- Active ingredients
- Perphenazine — 16 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205232
- Marketing start
- Listing expires
- Other FDA classes
- Phenothiazines (Chemical structure)
- Identifiers
- Product ID 70771-1044_e7ec4ac9-7976-4574-9837-56b48606144bSPL ID e7ec4ac9-7976-4574-9837-56b48606144bSPL set ID 003fe32c-a55d-4191-99fa-1013522b1b2eRxCUI 198075, 198076, 198077, 198078UNII FTA7XXY4EZUPC 0370771104215, 0370771104116
- Pharmacologic class
- Phenothiazine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771104401followed by a unit qualifier and the quantityPackage 70771-1044-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Perphenazine tablets, USP are indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine tablets, USP have not been shown effective for the management of behavioral complications in patients with mental retardation.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 205232
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| perphenazine | Perphenazine 8 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1043 |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1041 |
| perphenazine | Perphenazine 4 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1042 |
| perphenazine | Perphenazine 4 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-592 |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-591 |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-694 |
| perphenazine | Perphenazine 8 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-593 |
| perphenazine | Perphenazine 16 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-594 |
| perphenazine | Perphenazine 16 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-697 |
| perphenazine | Perphenazine 4 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-695 |
| perphenazine | Perphenazine 8 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-696 |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3257 |